Free Trial
OTCMKTS:RBCL

RBC Life Sciences (RBCL) Stock Price, News & Analysis

RBC Life Sciences logo

About RBC Life Sciences Stock (OTCMKTS:RBCL)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RBCL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RBC Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

RBCL Stock News Headlines

Edwards Lifesciences (EW) Receives a Buy from RBC Capital
RBC Capital Sticks to Their Buy Rating for Edwards Lifesciences (EW)
Forget AI Stocks — This Device Will REPLACE the Microchip
While everyone's chasing the same AI plays, George Gilder is focused on something completely different. He says a 4-nanometer device that's 80 MILLION times more powerful than the chip he gave Reagan is now being made in America for the first time. And he's identified 3 companies that control this technology.tc pixel
RBC Capital Sticks to Their Hold Rating for Wave Life Sciences (WVE)
Wave Life Sciences price target raised to $15 from $7 at RBC Capital
RBC Life Science and Technology (0P0001TAGA)
RBC Capital Reaffirms Their Hold Rating on BioMarin Pharmaceutical (BMRN)
RBC Capital Reaffirms Their Buy Rating on Edwards Lifesciences (EW)
See More Headlines

RBCL Stock Analysis - Frequently Asked Questions

Shares of RBCL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that RBC Life Sciences investors own include NVIDIA (NVDA), Arcadis (ARCVF), AdvancePierre Foods Holdings, I (APFH), Artisan Partners Asset Management (APAM), American Superconductor (AMSC), ARCAM/SH (AMAVF) and Allison Transmission (ALSN).

Company Calendar

Today
9/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Wholesale
Current Symbol
OTCMKTS:RBCL
CIK
830052
Employees
89
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (OTCMKTS:RBCL) was last updated on 9/14/2025 by MarketBeat.com Staff
From Our Partners